Related Experiment Video

Updated: Jun 12, 2026

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice
09:00

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice

Published on: August 2, 2018

Overexpression of SERCA1a in the mdx diaphragm reduces susceptibility to contraction-induced damage

Kevin J Morine1, Meg M Sleeper, Elisabeth R Barton

  • 1Department of Physiology, University of Pennsylvania School of Medicine, Philadelphia, 19104, USA. kmorine@gmail.com

Human Gene Therapy
|June 15, 2010
PubMed

Insights

Gene therapy targeting calcium regulation in Duchenne muscular dystrophy (DMD) showed promise. Enhancing the sarcoplasmic reticulum calcium pump in mdx mouse diaphragms reduced muscle damage, suggesting a potential therapeutic avenue for DMD.

Area of Science:

  • Biomedical Science
  • Molecular Biology
  • Muscle Physiology

Background:

  • Dystrophin deficiency in Duchenne muscular dystrophy (DMD) leads to muscle damage.
  • Calcium homeostasis is significantly disrupted in dystrophin-deficient muscles.
  • The sarcoplasmic reticulum calcium pump plays a crucial role in regulating intracellular calcium levels.

Purpose of the Study:

  • To investigate if increasing sarcoplasmic reticulum calcium pump expression can mitigate muscle damage in a mouse model of DMD.
  • To assess the therapeutic potential of sarcoplasmic reticulum ATPase 1a gene transfer.

Main Methods:

  • Neonatal adeno-associated virus (AAV) gene transfer was used to deliver sarcoplasmic reticulum ATPase 1a to the diaphragm of mdx mice.
  • Histological analysis (centrally located nuclei) and functional assessment (eccentric contraction-induced damage) were performed at 6 months of age.

Main Results:

  • Gene transfer of sarcoplasmic reticulum ATPase 1a led to a decrease in centrally located nuclei in the mdx diaphragm.
  • The treated diaphragms showed reduced susceptibility to eccentric contraction-induced damage.
  • These findings suggest improved muscle integrity and function.

Conclusions:

  • Enhanced cytosolic calcium removal via increased sarcoplasmic reticulum calcium pump activity is a viable therapeutic strategy for DMD.
  • The diaphragm, as a representative muscle in this model, shows promise for gene therapy interventions.
  • Further research into targeting calcium handling mechanisms is warranted for DMD treatment.

More Related Videos

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

Isometric and Eccentric Force Generation Assessment of Skeletal Muscles Isolated from Murine Models of Muscular Dystrophies14:10

Isometric and Eccentric Force Generation Assessment of Skeletal Muscles Isolated from Murine Models of Muscular Dystrophies

Published on: January 31, 2013

Related Concept Videos

Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...